Current status: 894 hESC lines, 3882 hiPSC lines, and 114 clinical studies, and 777 certificates
Monthly statistic from May 1, 2023
Posted on May 1, 2023
| total lines | 4776 |
| hESC lines | 894 |
| hiPSC lines | 3882 |
| derivation countries | 45 |
| projects | 268 |
| providers | 810 |
| clinical studies | 114 |
| subclones | 2093 |
| certificates | 777 |
| cell line certificates | 641 |
| project certificates | 136 |